A single tumor of abnormal plasma cells, typically found in bone or soft tissue.
During the active disease or treatment phase, medical records confirming the diagnosis and showing ongoing disease or a current treatment plan are central. Records documenting surgery, radiation, chemotherapy, or stem cell transplantation — and their dates — establish that a treatment phase was underway and support the 100% rating through the required continuation period. After treatment ends, a VA examination six months later will look for signs of recurrence or residual conditions. If there is no recurrence, records and exam findings that document specific residuals — for example, imaging or lab results showing thrombosis, or nerve conduction studies showing neuropathy — help establish ratings for those conditions under the codes that govern them. If the condition has progressed to multiple myeloma, records confirming that diagnosis shift the rating basis. Statements from you or treating providers describing how symptoms or treatment side effects affect your daily activities and work can support the overall picture of your condition at each stage.
Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.
